Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06319079
Other study ID # UCTH 2024
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date March 2024
Est. completion date July 2027

Study information

Verified date March 2024
Source Instituto de Desarrollo e Investigaciones Pediátricas Prof. Dr. Fernando E. Viteri
Contact Maria Florencia Andreoli, PhD
Phone +542214177324
Email mfandreoli@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Vulnerable populations, who have deficient diets, may produce human milk (HML) that is not adequate in all nutrients and this will have consequences on the growth and development of the child. In 2021 at IDIP, a specific milk product for pregnant and lactating women Super Mil Mamá ( SMM, whole milk powder fortified with multiple vitamins, minerals and DHA ) has been designed and developed as part of a key strategy to incorporate in public policies for the first 1000 days of life. However, the potential benefits of this product have not yet been evaluated at the population level. The main objective is to evaluate the effect of the consumption of a milk product (SMM) designed for lactating women on the composition of human milk and the nutritional status of iron and DHA in infant red blood cells in a vulnerable population through a randomized, triple-blind, controlled clinical trial. Specific objectives To compare the concentrations of DHA, Vitamins A, E, and D, Iron, Iodine, Zinc and Calcium in human milk before and after dietary supplementation with SMM. To compare the concentrations of DHA, Vitamins A, E, D and Zinc in blood and the nutritional status of maternal iron before and after dietary supplementation with SMM. To analyze the relationship between micronutrients measured in maternal blood and human milk after dietary supplementation with SMM. To compare the concentrations of micronutrients measured in blood and human milk in women who received SMM and those who received commercial milk (CM) at the end of supplementation. To compare the iron nutritional status and DHA content in red blood cells of infants of mothers who consumed SMM or LC. To evaluate the relationship between the concentration of micronutrients in human milk and infant growth during the first six months of life.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 120
Est. completion date July 2027
Est. primary completion date March 2026
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria: - Women who attend their child's first check-up within the first month of life, who breastfeed their children, and who consume milk regularly. Exclusion Criteria: - Women who have had multiple pregnancies, who receive vitamin or mineral supplements that interfere with the results of the study, and/or women with malabsorption diseases.

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Fortified powder milk
Super 1.000 Mamá It's made up of milk with added vegetable oils, fish oil, carbohydrates from corn, prebiotic fiber (inulin), vitamins, and minerals, with specifically defined proportions. It has medium energy content, is balanced in protein, fats, and carbohydrates, and provides a significant content of both polyunsaturated fatty acids, such as omega-6, and omega-3, and the added docosahexaenoic acid, as recommended by international organizations. The reconstituted 200 ml serving delivers between 20 and 40% of the Daily Reference Intake in critical nutrients for this particular group of people, which include minerals such as calcium, iron, zinc, iodine, and vitamins such as A, D, C, B12 and folic acid. The rest of the vitamins, and minerals are also at the same level, allowing those who consume it to incorporate a large amount of nutrients regularly. Addvance SA, an SME dairy company from the Province of Santa Fe, will carry out the production of this milk.
Other:
Powder milk
Commercial powder milk constitutes dehydrated commercially available cow's milk, which is fortified with Vitamins A and D by law.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Instituto de Desarrollo e Investigaciones Pediátricas Prof. Dr. Fernando E. Viteri

Outcome

Type Measure Description Time frame Safety issue
Primary breast milk DHA concentration concentration of DHA in breast milk expressed as a percentage of DHA with respect to the total fatty acids contained in the analyzed sample breast milk DHA concentration will assessed before starting the intervention (one month postpartum) and at the end of it (fourth month postpartum)
Primary breast milk Vitamin A concentration Retinol concentration in breast milk expressed in µmol/L and µg/g fat contained in the analyzed sample breast milk Vitamin A concentration will assessed before starting the intervention (one month postpartum) and at the end of it (fourth month postpartum)
Primary breast milk Vitamin E concentration a-tocopherol concentration in breast milk expressed in µmol/L and µg/g fat contained in the analyzed sample breast milk Vitamin E concentration will assessed before starting the intervention (one month postpartum) and at the end of it (fourth month postpartum)
Primary breast milk Vitamin D concentration 25-hidroxi vitamin D concentration in breast milk expressed in ng/ml breast milk Vitamin D concentration will assessed before starting the intervention (one month postpartum) and at the end of it (fourth month postpartum)
Primary breast milk Zinc concentration Zinc concentration in breast milk expressed in mg/dl breast milk Zinc concentration will assessed before starting the intervention (one month postpartum) and at the end of it (fourth month postpartum)
Primary breast milk Calcium concentration Calcium concentration in breast milk expressed in mg/dl breast milk Calcium concentration will assessed before starting the intervention (one month postpartum) and at the end of it (fourth month postpartum)
Primary breast milk Iron concentration Calcium concentration in breast milk expressed in mg/dl breast milk Iron concentration will assessed before starting the intervention (one month postpartum) and at the end of it (fourth month postpartum)
Primary breast milk Iodine concentration Iodine concentration in breast milk expressed in mg/dl breast milk Iodine concentration will assessed before starting the intervention (one month postpartum) and at the end of it (fourth month postpartum)
Secondary mother red blood cell DHA concentration concentration of DHA in mother red blood cell expressed as a percentage of DHA with respect to the total fatty acids contained in the analyzed sample mother serum DHA concentration will assessed before starting the intervention (one month postpartum) and at the end of it (fourth month postpartum)
Secondary mother Vit A concentration Retinol concentration in mother serum expressed in µmol/L mother Vit A concentration will assessed before starting the intervention (one month postpartum) and at the end of it (fourth month postpartum)
Secondary mother Vit E concentration a-tocopherol concentration in mother serum expressed in µmol/L mother Vit E concentration will assessed before starting the intervention (one month postpartum) and at the end of it (fourth month postpartum)
Secondary mother Vit D concentration 25-hidroxi vitamin D concentration in mother serum expressed in ng/ml mother Vit D concentration will assessed before starting the intervention (one month postpartum) and at the end of it (fourth month postpartum)
Secondary mother Zinc concentration Zinc concentration in mother serum expressed in mg/dl mother Zinc concentration will assessed before starting the intervention (one month postpartum) and at the end of it (fourth month postpartum)
Secondary mother hemoglobin concentration hemoglobin concentration in mother serum expressed in g/dL mother hemoglobin concentration will assessed before starting the intervention (one month postpartum) and at the end of it (fourth month postpartum)
Secondary mother serum ferritin concentration ferritin concentration in mother serum expressed in ng/ml mother serum ferritin concentration will assessed before starting the intervention (one month postpartum) and at the end of it (fourth month postpartum)
Secondary child hemoglobin concentration hemoglobin concentration in child serum expressed in g/dL child hemoglobin concentration will assessed before starting the intervention (one month postpartum) and at the end of it (fourth month postpartum)
Secondary child serum ferritin concentration ferritin concentration in child serum expressed in ng/ml child serum ferritin concentration will assessed before starting the intervention (one month postpartum) and at the end of it (fourth month postpartum)
Secondary child red blood cell DHA concentration concentration of DHA in child red blood cell expressed as a percentage of DHA with respect to the total fatty acids contained in the analyzed sample child red blood cell DHA concentration concentration will assessed before starting the intervention (one month postpartum) and at the end of it (fourth month postpartum)
See also
  Status Clinical Trial Phase
Withdrawn NCT01953562 - Positioning and the Spontaneous Breathing Test in Neonates N/A
Completed NCT03716882 - Acoustic Structures Crying of Infants From 1 to 4 Months and Their Signification
Recruiting NCT06353841 - Effect of Therapeutic Touch on Functional Constipation in Infants and Young Children N/A
Completed NCT06447558 - The Effects of "Oral Administration of Breast Milk Droplets" and "Palatal Stimulation With a Finger" N/A
Recruiting NCT05705258 - A Study to Collect Data on the Use of Eylea in Babies Born Too Early Who Have a Condition of the Eye Where Blood Vessels Grow Abnormally in the Retina (Retinopathy of Prematurity)
Completed NCT02119104 - Prevenar (13v) Infant Drug Use Investigation N/A
Recruiting NCT06318858 - Daily and Weekly Iron Supplementation in Infants N/A
Not yet recruiting NCT03047876 - Brain Vascular Reactivity to Hypothermic Circulatory Arrest With Antegrade Cerebral Perfusion During Aortic Arch Surgery
Withdrawn NCT05266677 - DHA Proof-of-Concept Study in Infants and Toddlers N/A
Recruiting NCT05940688 - Providing an Optimized and emPowered Pregnancy for You (PᵌOPPY) Feasibility Study N/A
Not yet recruiting NCT06127914 - Learning Early Infant Feeding Cues N/A
Completed NCT05492253 - First Complementary Foods and the Infant Gastrointestinal Microbiota N/A
Completed NCT03327415 - Nutri-Bébé 2013 Survey on Food Consumption of Infants and Young Children N/A
Completed NCT04598841 - Nutrition Support for Hirschsprung Disease N/A
Completed NCT01664234 - Oxygen Insuflation and ArterialDesaturation During Tracheal Intubation in Children N/A
Terminated NCT02069522 - Healthy Term Infants Fed Milk-Based Formulas N/A
Completed NCT04218929 - Evaluation of Growth, Safety, and Efficacy of an Infant Formula for Healthy Term Infants N/A
Recruiting NCT01575184 - Effect of Shoulder Traction on Size and Relative Position of Internal Jugular Vein to Carotid Artery N/A
Not yet recruiting NCT05994417 - Beyond Race: Objectively Assessed Skin Color and Its Association With Pulse Oximeter Bias in Critically Ill Infants